Cite

HARVARD Citation

    Iyer, R. et al. (2018). A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer. American journal of clinical oncology. p. . [Online]. 
  
Back to record